Skip to content
Navigating Diabetes Care Wave I — HIO pharmacists in training session, Cairo, May 2025
Pharmacist Capability Program · SL03
Navigating Diabetes Care

Insulin Safety at the Point of Dispense

5 min read

A substitution decision made without full clinical context can put a patient at real risk. Navigating Diabetes Care was built to close that gap.

1
Wave Delivered
3
Professor Speakers
Cairo
May 2025
Client Roche
Audience HIO Pharmacists — HIO Diabetes Centers
Under Patronage Health Insurance Organization
Scale 1 wave — Elmokatam HIO Training Center, Cairo
Read 5 min
01The Challenge

Where a substitution decision becomes a patient outcome.

HIO pharmacists sit at the point where insulin prescriptions become patient outcomes, and where a substitution decision made without full clinical context can put a patient at real risk. Working with HIO's medical supply team, we identified a knowledge gap that had not been formally addressed: how insulin types differ, when substitution is clinically safe and when it is not, and how insulin protocols differ between Type 1 and Type 2 diabetes.

Standard pharmacist training in Egypt does not cover this ground with the specificity that patient safety demands. The gap sat quietly at the dispensing counter, the last checkpoint before a prescription becomes what a patient actually takes.

02The Signature Move

Designed around the real gap, not around available content.

Four decisions defined how Navigating Diabetes Care works, from a gap analysis with HIO's own team to a curriculum shaped by the pharmacists asking the questions.

01

Gap analysis with HIO's medical supply team

We ran the gap analysis directly with the internal function that sees where substitution decisions actually happen, and where they go wrong.

02

A questionnaire built from real concerns

From that analysis we built the pre-training questionnaire that mapped every pharmacist's specific concerns before the wave: not an assumed gap.

03

Questions routed to the speakers

Pharmacists' own clinical questions were collected and routed to the professors, so the curriculum answered what the audience actually needed to hear.

04

A curriculum built on specificity

The pharmacist's role in diabetes, T1DM in children and adolescents, insulin types, glucose monitoring, nutrition, and T2DM diagnosis, classification, and management.

Navigating Diabetes Care Wave I — panel under HIO patronage, Chairman of the Health Insurance Organization and department heads
Wave in Motion

Delivered under the patronage of the Health Insurance Organization, the same institutional weight behind every HIO pharmacist in the room.

03How We Did It

One substitution decision. Four clinical checkpoints.

Built as a decision tree, not a lecture list.

The curriculum was structured around the actual decision a pharmacist makes at the counter: is this substitution safe, and does the protocol change if the patient is T1DM or T2DM? Insulin types, glucose monitoring, and nutrition sit around that central decision: not as separate topics, but as the inputs that determine the answer.

The speakers, Prof. Mona Atteya, Prof. Sameh Tawfik, and Prof. Mohamed Reda Halawa, walked pharmacists through each checkpoint using the questions the audience had submitted before the wave, so every session answered a real concern from the floor of an HIO diabetes center.

Input

Pre-Training Questionnaire

Built with HIO's medical supply team, mapped every pharmacist's specific concerns before the wave.

Output
Professor-Led Sessions

Three speakers answered the submitted questions directly, same specificity the gap analysis demanded.

The Substitution Decision Insulin Types T1DM Protocol T2DM Protocol Glucose Monitoring
04Proof — Impact

A gap not previously closed at this level.

Same assessment instrument, pre-training and post-training, Navigating Diabetes Care's first wave delivered specificity Egypt's standard pharmacist training does not provide.

30—40%
Pre-Training Baseline

Consistent baseline for HIO pharmacists on insulin substitution and T1DM vs T2DM protocols, measured on the same instrument used post-training.

75—80%
Post-Training Score

Post-training improvement on the same MCQ instrument, pharmacists leave with applied insulin-safety judgment, not just protocol recall.

Open
For Expansion

The program remains open for expansion across additional HIO training centers beyond Wave I.

A foundation program for HIO pharmacists on insulin safety.

05The Partnership

Sponsor, patronage, and the speakers in the room.

Named credit, because the credibility of a specificity-first program lives in who built it and who taught it.

Corporate Sponsor & Institutional Partner

Professor Speakers — Who Taught the Program

Prof. Mona Atteya

Prof. Mona Atteya

Professor of Pediatrics & Pediatric Endocrinology, Cairo University
Prof. Sameh Tawfik

Prof. Sameh Tawfik

Professor of Pediatrics & Pediatric Endocrinology, Military Medical Academy
Prof. Mohamed Reda Halawa

Prof. Mohamed Reda Halawa

Professor of Internal Medicine & Endocrinology, Ain Shams University
HIO patronage seal
Under Patronage Of

Chairman of the Health Insurance Organization

With the General Manager of the Training & Cultural Relations Department, and the Head of the Central Administration of Medical Supply & Pharmacies.

06What This Case Proves

Four principles the next capability program can inherit.

The reusable pattern, what Navigating Diabetes Care makes true for the next specificity-first HCP engagement Roadmap builds.

Principle 01

Design around the real gap, not available content.

Principle 02

Specificity is what standard training cannot offer.

Principle 03

A single wave can still open a full program.

Principle 04

The audience's own questions are the curriculum.

Start a Conversation

Ready to move a decision forward? Let's talk through where you are and whether Roadmap can help.

We use your details only to reply to this enquiry. Prefer email? info@roadmapeg.com